ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2439

Effect of Pregnancy Counseling on the Outcome of Pregnancies in Women with Systemic Lupus Erythematosus: A Prospective Observational Study

Rebecca Fischer-Betz1, Lisa Kueppers2, Ralph Brinks2, Oliver Sander3, Christof Specker4 and Matthias Schneider3, 1Policlinic of Rheumatology and Hiller Research Unit Rheumatology, Heinrich-Heine University, Duesseldorf, Duesseldorf, Germany, 2Department of Rheumatology&Hiller Research Unit, Heinrich-Heine-University, Duesseldorf, Germany, 3Department of Rheumatology & Hiller Research Unit, Heinrich-Heine-University, Duesseldorf, Germany, 4Rheumatology and Clinical Immunology, Kliniken Essen Sued, Essen, Germany

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Counseling, pregnancy, systemic lupus erythematosus (SLE) and women's health

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: Reproductive Issues in Rheumatic Disorders - Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Pregnancies in women with systemic lupus erythematosus (SLE) are associated with increased frequencies of adverse pregnancy outcomes (APOs). Preconception counseling including risk stratification and adjustment of medication is strongly recommended by EULAR1. However, a considerable number of women with SLE do not seek such advice before conception. Our aim was to assess the impact of pregnancy counseling prior to conception on the outcome of pregnancies in women with SLE referred to our lupus pregnancy clinic (2000-2015).

Methods: All pregnancies in women with SLE who received an individual pregnancy counseling prior to conception were prospectively followed during pregnancy and postpartum period according to a standard protocol (group A). Outcome of these pregnancies was compared to pregnancies in women with SLE who were already pregnant by the time of their first appointment in our clinic (group B). APOs were defined as fetal loss (spontaneous abortion or stillbirth), severe pregnancy disorders (preeclampsia, HELLP-syndrome), birth before 36 weeks (due to placental insufficiency, hypertension, or preeclampsia) and low birth weight (< 2500 g). Systemic Lupus Erythematosus Pregnancy Disease Activity Index (SLEPDAI) was used to gauge disease activity during pregnancy.

Results: A total of 188 pregnancies in 151 women with SLE (median age 31 years) were included (group A = 137; group B = 51). 67 % of all women had been pregnant before, 33 % had experienced at least one fetal loss and 9 % severe pregnancy disorders. With respect to all pregnancies, a live birth was documented in 172 (91.5 %) [group A 94.2% vs group B 86.3 %)]. A fetal loss occurred in 16 (8.5 %) pregnancies [group A 5.8 % vs. group B 15.7 %). Twenty-three (12.2%) of all pregnancies were complicated by severe pregnancy disorders (group A 5.8 % vs group B 29.4 %) and 28 (14.9 %) by preterm birth (group A 7.3 %; group B 35.3 %). One newborn (group B) died shortly after extreme preterm birth. After adjusting for maternal age and for higher disease activity in the first trimester (SLEPDAI ≥ 4) we observed significantly higher rates of fetal losses (RR = 3.4; 95%CI 1.4-8.6), severe pregnancy disorders (RR = 5.5; 95%CI 2.5 – 12.1), preterm birth (RR = 5.6; 95%CI 2.8 – 11.2) and low birth weight (RR = 3.2; 95%CI 1.9 – 5.4) in group B compared to group A.

Conclusion: The main prognostic risk factor for adverse outcomes in our observational cohort of 188 SLE-pregnancies was the lack of preconception counseling. These patients had significant higher risks of fetal loss, preterm birth, low birth weight and severe pregnancy disorders. Though our observed live birth rate was considerable high in both groups, probably due to an adapted multidisciplinary management during the course of pregnancy, consultation before conception was still associated with higher live birth rates (94,2 vs. 86,3%). Women with SLE and pregnancy wish should be informed about the obvious beneficial effect of preconception counseling. 1Andreoli L. “EULAR recommendations for women’s health and the management of family planning, assisted reproduction, pregnancy, and menopause in patients with Systemic Lupus Erythematosus and/or the Antiphospholipid Syndrome.” (in press)


Disclosure: R. Fischer-Betz, None; L. Kueppers, None; R. Brinks, None; O. Sander, None; C. Specker, None; M. Schneider, None.

To cite this abstract in AMA style:

Fischer-Betz R, Kueppers L, Brinks R, Sander O, Specker C, Schneider M. Effect of Pregnancy Counseling on the Outcome of Pregnancies in Women with Systemic Lupus Erythematosus: A Prospective Observational Study [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/effect-of-pregnancy-counseling-on-the-outcome-of-pregnancies-in-women-with-systemic-lupus-erythematosus-a-prospective-observational-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/effect-of-pregnancy-counseling-on-the-outcome-of-pregnancies-in-women-with-systemic-lupus-erythematosus-a-prospective-observational-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology